Search

everythinglearnresearchcommunity

for

Search:↓

Acne can't be cured but can be managed with treatments like benzoyl peroxide and diet changes; it's costly and can lead to scarring and mental health issues.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Gut health affects skin diseases, and probiotics might help.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

Autologous platelet concentrates show promise in esthetic treatments but need more standardized research.

The Wnt/β-catenin pathway is important for body functions and diseases, and targeting it may treat conditions like cancer, but with safety challenges.

The conclusion is to use scalp cooling, gentle hair care, and treatments like minoxidil for managing hair loss from chemotherapy, and stresses the need for more research and collaboration in this area.

TGF-β is crucial for tissue repair and can cause diseases if not properly regulated.

Increased HIF-1α is linked to the inflammation and severity of hidradenitis suppurativa, suggesting treatments that lower HIF-1α could help.

Anti-TNF therapy can cause hair loss and skin issues.

Hormonal imbalances in Polycystic Ovarian Syndrome (PCOS) might trigger a rare skin disorder called Confluent and Reticulated Papillomatosis (CRP), so dermatologists should consider checking for PCOS in CRP patients.

Electrospun matrices help regenerate skin and hair follicles using PCL and collagen scaffolds.

Natural skincare products may help reduce sun damage and support the skin's daily cycle.

Activin B helps start and grow hair follicles in mice.

Obstetrician/gynecologists can diagnose and manage female hair loss with careful history taking and examination.

The conclusion is that certain cell interactions and signals are crucial for hair growth and regeneration.

Phytotherapeutic compounds and supplements can help manage Polycystic Ovarian Syndrome (PCOS).

The conclusion is that proper evaluation and treatment of hair loss in midlife women is important, considering the emotional impact and potential for various treatments.

The conclusion is that obesity should be managed with a slow, balanced approach to diet and exercise, with medication and surgery as additional options, and education and access to care are important.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Quercetin may help improve symptoms of polycystic ovary syndrome.

No clear link between hair loss and metabolic syndrome, but some differences in blood pressure and glucose levels.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Prolactin affects the production of different keratins in human hair, which could lead to new treatments for skin and hair disorders.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Marine microbes could be used in cosmetics for sun protection, skin care, and possibly preventing hair loss.

Secretome-based therapies could improve hair growth better than current treatments.

Possible new treatments for common hair loss include drugs, stem cells, and improved transplants.